| | Germany will lift most restrictions to contain the coronavirus despite infections hitting a record in the country on Thursday. | | | British drugmaker AstraZeneca Plc will pay $775 million to settle a patent dispute with Japan's Chugai Pharmaceutical Co Ltd related to rare disease treatment Ultomiris, it said on Thursday. | | | A board of experts advising the Italian government on the COVID-19 crisis will be disbanded when the national state of emergency ends on March 31, Prime Minister Mario Draghi said on Thursday. | | | Italy reported 79,895 COVID-19 related cases on Thursday, against 72,568 the day before, the health ministry said, while the number of deaths fell to 128 from 137. | | | An AstraZeneca Plc executive said the British drugmaker would consider not submitting its COVID-19 vaccine for approval in the United States if the regulatory process takes too long, the Financial Times reported on Thursday. | | | Britain will allow Ukrainian war refugees immediate access to its publicly-funded healthcare system free of charge, the department of health and social care said on Thursday. | | | Alnylam Pharmaceuticals Inc on Thursday filed lawsuits in Delaware federal court against Pfizer Inc and Moderna Inc , claiming their multibillion-dollar mRNA COVID-19 vaccines infringe one its patents. | | | Britain's medicines regulator has approved AstraZeneca's antibody-based COVID-19 treatment for preventing infections in adults with poor immune response, marking a major step in the fight against the pandemic as infections surge globally. | | | Moderna Inc said on Thursday Canada authorized its COVID-19 vaccine for use in children between 6 and 11 years of age. | | | Five districts in China's southern city of Shenzhen that have achieved "community-wide COVID-19 dynamic clearance" can restart work and resume public transport from March 18, the municipality government said late on Thursday. | | | | |